Jump to content

Navy Continues COVID-19 Vaccine Separations as Fourth Vaccine Eyes Conditional FDA Approval

Recommended Posts

Some sailors have received a COVID-19 vaccine that is developed differently from existing vaccines and could overcome religious objections that have been fought over in federal court.

A small percentage of sailors received Novavax COVID-19 while overseas, where the shot is considered approved, said Ed Gulick, a spokesperson for Navy medicine.

Novavax is seeking emergency use authorization from the FDAA for its version of a COVID-19 vaccine. However, that approval could be delayed, according to Axios. Novavax developed a protein-based vaccine, which is a common method for vaccines, against COVID-19. Some have theorized that those uncomfortable with the mRNA vaccines from Pfizer and Moderna due to their reliance on a certain line of fetal cells and idea that the mRNA changes their bodies may be more willing to get the Novavax option, according to science journal Nature.

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

  • 🧧 Activity Stream

    1. 0

      Navy Medicine Announces FY23 Sailor of the Year

    2. 0

      USS George Washington to Depart for Japan via South America

    3. 0


  • Create New...
Forum Home
Boots | Navy Patches
Serving enlisted, veterans, spouses & family